Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,143Revenue $M581Net Margin (%)55.2Z-Score4.9
Enterprise Value $M1,301EPS $1.9Operating Margin %92.0F-Score3
P/E(ttm))3.9Cash Flow Per Share $1.5Pre-tax Margin (%)85.8Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsN
Price/Sales2.15-y EBITDA Growth Rate %19.4Current Ratio1.9Lower Leverage y-yN
Price/Cash Flow5.0y-y EBITDA Growth Rate %14.9ROA % (ttm)37.9Higher Current Ratio y-yY
Dividend Yield %8.6Insider Buy (3m)1ROE % (ttm)109Less Shares Outstanding y-yN
Payout Ratio %32.0Shares Outstanding M163ROI % (ttm)162Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 7.02-13%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 7.02-32%Reduce -96.71%25,997
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 7.02-27%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 7.02-22%Reduce -50.19%1,665,543
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 7.02-15%Add 24.84%2,890,564
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 7.02-1%Add 23.50%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 7.02-10%Add 561.89%1,729,133
PDLISeth Klarman 2012-03-31 Sold Out -1.5%$6.02 - $6.58
($5.93)
$ 7.0216%Sold Out0
PDLIJoel Greenblatt 2012-03-31 Add0.04%$6.02 - $6.58
($5.93)
$ 7.0216%Add 33.54%270,346
PDLISeth Klarman 2011-12-31 Reduce-1.4%$5.35 - $6.4
($5.97)
$ 7.0215%Reduce -48.84%8,000,000
PDLIJoel Greenblatt 2011-12-31 Add0.04%$5.35 - $6.4
($5.97)
$ 7.0215%Add 31.29%202,444
PDLIGeorge Soros 2011-12-31 Sold Out -0.001%$5.35 - $6.4
($5.97)
$ 7.0215%Sold Out0
PDLISeth Klarman 2011-09-30 Add1.17%$5.47 - $6.39
($5.91)
$ 7.0216%Add 68.81%15,636,000
PDLIJoel Greenblatt 2011-09-30 Add0.04%$5.47 - $6.39
($5.91)
$ 7.0216%Add 41.81%154,201
PDLIGeorge Soros 2011-09-30 Buy $5.47 - $6.39
($5.91)
$ 7.0216%New holding10,000
PDLIGeorge Soros 2011-06-30 Sold Out $5.74 - $6.64
($6.23)
$ 7.0211%Sold Out0
PDLISeth Klarman 2011-03-31 Add1.6%$4.69 - $6.36
($5.38)
$ 7.0223%Add 87.30%10,495,225
PDLIJoel Greenblatt 2011-03-31 Add0.12%$4.69 - $6.36
($5.38)
$ 7.0223%Add 128.09%126,863
PDLIJean-Marie Eveillard 2011-03-31 Reduce$4.69 - $6.36
($5.38)
$ 7.0223%Reduce -99.92%2,800
PDLIGeorge Soros 2011-03-31 Buy $4.69 - $6.36
($5.38)
$ 7.0223%New holding16,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-12view
Lindell Jody SDirector 2011-03-15Buy374$5.3333.4view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.7124.52view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.1815.05view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-14.65view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-8.38view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-3.66view
SANDMAN PAUL WDirector 2009-04-08Buy10,000$7.38-3.66view
KLEIN JOSEPH IIIDirector 2008-05-20Buy500$9.5-25.16view
KLEIN JOSEPH IIIDirector 2008-05-06Buy500$9.6-25.94view

Press Releases about PDLI :

    Quarterly/Annual Reports about PDLI:

    News about PDLI:

    Articles On GuruFocus.com
    SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against PDL BioPharma, Oct 17 2014 
    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against PDL BioPharma Inc Oct 15 2014 
    Hot Picks with High Yields Jul 23 2013 
    My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
    comment on PDLI May 12 2013 
    My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
    FV 22 MSN 10 Apr 19 2013 
    68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
    20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 
    comment on PDLI Nov 13 2012 

    More From Other Websites
    PDL BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 23 2015
    Huge Biotech Index Rebalance Means Massive Buy Orders for These 4 Stocks Apr 17 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Apr 01 2015
    PDL BioPharma Completes Regular Quarterly Dividend Payment Mar 12 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 12 2015
    PDL BioPharma Completes Regular Quarterly Dividend Payment Mar 12 2015
    Top Stocks to Buy That Wall Street Analysts Do Not Follow Mar 06 2015
    PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note Mar 04 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 04 2015
    PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note Mar 04 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 03 2015
    PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit Mar 03 2015
    PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit Mar 03 2015
    PDL BioPharma Announces Fourth Quarter and Full Year 2014 Financial Results Mar 03 2015
    PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 Mar 03 2015
    PDL BIOPHARMA, INC. Financials Feb 28 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 26 2015
    PDL BioPharma to Hold Annual Meeting of Stockholders on May 28, 2015 Feb 26 2015
    10-K for PDL BioPharma, Inc. Feb 25 2015
    PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Feb 25 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK